§ 21-31-16. Sale of new drugs — Regulations and procedure — Exceptions.
(a) No person shall sell, deliver, offer for sale, hold for sale, or give away any new
drug unless:
(1)an application with respect to the new drug has become effective
under § 505 of the Federal Act, 21 U.S.C. § 355; or (2) when not subject to the Federal Act unless the drug has been tested and has
not been found to be unsafe for use under the conditions prescribed, recommended,
or suggested in the labeling of it, and prior to selling or offering for sale the
drug, there has been filed with the director of health an application setting forth: (i)full reports of investig
Free access — add to your briefcase to read the full text and ask questions with AI
§ 21-31-16. Sale of new drugs — Regulations and procedure — Exceptions.
(a) No person shall sell, deliver, offer for sale, hold for sale, or give away any new
drug unless: (1) an application with respect to the new drug has become effective
under § 505 of the Federal Act, 21 U.S.C. § 355; or (2) when not subject to the Federal Act unless the drug has been tested and has
not been found to be unsafe for use under the conditions prescribed, recommended,
or suggested in the labeling of it, and prior to selling or offering for sale the
drug, there has been filed with the director of health an application setting forth:
(i) full reports of investigations which have been made to show whether or not the
drug is safe for use; (ii) a full list of the articles used as components of the drug;
(iii) a full statement of the composition of the drug; (iv) a full description of
the methods used in, and the facilities and controls used for, the manufacture, processing,
and packing of the drug; (v) any samples of the drug and of the articles used as components
of it that the director of health may require; and (vi) specimens of the labeling
proposed to be used for the drug.
(b) An application provided for in subdivision (a)(2) of this section shall become effective
on the sixtieth (60th) day after the filing of it, except that if the director of
health finds after due notice to the applicant and giving the applicant an opportunity
for a hearing that the drug is not safe for use under the conditions prescribed, recommended,
or suggested in its proposed labeling, the director shall, prior to the effective
date of the application, issue an order refusing to permit the application to become
effective.
(c) This section shall not apply:
(1) To a drug intended solely for investigational use by experts qualified by scientific
training and experience to investigate the safety in drugs provided the drug is plainly
labeled "For investigational use only�;
(2) To a drug sold in this state at any time prior to the enactment of this chapter or
introduced into interstate commerce at any time prior to the enactment of the Federal
Act; or
(3) To any drug licensed under 42 U.S.C. § 262.
(d) An order refusing to permit an application under this section to become effective
may be revoked by the director of health.